advertisement
De Moraes CG 38
Showing records 1 to 25 | Display all abstracts from De Moraes CG112210 A Model of Progression to Help Identify Macular Damage Due to Glaucoma
Hood DC
Investigative Ophthalmology and Visual Science 2023; 64: 8
112101 Glaucoma Detection Using Optical Coherence Tomography: Reviewing the Pitfalls of Comparison to Normative Data
Leshno A
Journal of Glaucoma 2024; 33: 65-77
112704 Calcium Channel Blocker Use and Associated Glaucoma and Related Traits Among UK Biobank Participants
Kastner A
JAMA ophthalmology 2023; 141: 956-964
112176 Validating Trend-Based End Points for Neuroprotection Trials in Glaucoma
Montesano G
Translational vision science & technology 2023; 12: 20
112210 A Model of Progression to Help Identify Macular Damage Due to Glaucoma
La Bruna S
Investigative Ophthalmology and Visual Science 2023; 64: 8
112176 Validating Trend-Based End Points for Neuroprotection Trials in Glaucoma
Garway-Heath DF
Translational vision science & technology 2023; 12: 20
112101 Glaucoma Detection Using Optical Coherence Tomography: Reviewing the Pitfalls of Comparison to Normative Data
De Moraes CG
Journal of Glaucoma 2024; 33: 65-77
112210 A Model of Progression to Help Identify Macular Damage Due to Glaucoma
La Bruna S
Investigative Ophthalmology and Visual Science 2023; 64: 8
112101 Glaucoma Detection Using Optical Coherence Tomography: Reviewing the Pitfalls of Comparison to Normative Data
De Moraes CG; De Moraes CG
Journal of Glaucoma 2024; 33: 65-77
112704 Calcium Channel Blocker Use and Associated Glaucoma and Related Traits Among UK Biobank Participants
Stuart KV
JAMA ophthalmology 2023; 141: 956-964
112101 Glaucoma Detection Using Optical Coherence Tomography: Reviewing the Pitfalls of Comparison to Normative Data
De Moraes CG; Tsamis E
Journal of Glaucoma 2024; 33: 65-77
112176 Validating Trend-Based End Points for Neuroprotection Trials in Glaucoma
Rabiolo A
Translational vision science & technology 2023; 12: 20
112101 Glaucoma Detection Using Optical Coherence Tomography: Reviewing the Pitfalls of Comparison to Normative Data
Tsamis E
Journal of Glaucoma 2024; 33: 65-77
112704 Calcium Channel Blocker Use and Associated Glaucoma and Related Traits Among UK Biobank Participants
Montesano G
JAMA ophthalmology 2023; 141: 956-964
112101 Glaucoma Detection Using Optical Coherence Tomography: Reviewing the Pitfalls of Comparison to Normative Data
Tsamis E
Journal of Glaucoma 2024; 33: 65-77
112210 A Model of Progression to Help Identify Macular Damage Due to Glaucoma
Leshno A
Investigative Ophthalmology and Visual Science 2023; 64: 8
112704 Calcium Channel Blocker Use and Associated Glaucoma and Related Traits Among UK Biobank Participants
De Moraes CG
JAMA ophthalmology 2023; 141: 956-964
112176 Validating Trend-Based End Points for Neuroprotection Trials in Glaucoma
De Moraes CG
Translational vision science & technology 2023; 12: 20
112704 Calcium Channel Blocker Use and Associated Glaucoma and Related Traits Among UK Biobank Participants
De Moraes CG
JAMA ophthalmology 2023; 141: 956-964
112210 A Model of Progression to Help Identify Macular Damage Due to Glaucoma
Gomide GA
Investigative Ophthalmology and Visual Science 2023; 64: 8
112176 Validating Trend-Based End Points for Neuroprotection Trials in Glaucoma
De Moraes CG; De Moraes CG
Translational vision science & technology 2023; 12: 20
112101 Glaucoma Detection Using Optical Coherence Tomography: Reviewing the Pitfalls of Comparison to Normative Data
La Bruna S
Journal of Glaucoma 2024; 33: 65-77
112704 Calcium Channel Blocker Use and Associated Glaucoma and Related Traits Among UK Biobank Participants
De Moraes CG; De Moraes CG
JAMA ophthalmology 2023; 141: 956-964
112176 Validating Trend-Based End Points for Neuroprotection Trials in Glaucoma
De Moraes CG
Translational vision science & technology 2023; 12: 20
112101 Glaucoma Detection Using Optical Coherence Tomography: Reviewing the Pitfalls of Comparison to Normative Data
La Bruna S
Journal of Glaucoma 2024; 33: 65-77
